Printer Friendly

Gene therapy thwarts hepatitis C in mice. (Infectious Diseases).

Gene therapy that induces infected liver cells to self-destruct slows hepatitis C dramatically in mice, scientists report.

Christopher D. Richardson of the Ontario Cancer Institute in Toronto and his colleagues implanted human liver cells into mice and infected the animals with the hepatitis C virus. The researchers then gave the mice three injections. Some got a self-destruct gene housed in an adenovirus that shuttles the gene into liver cells. Others received adenovirus without the therapeutic gene.

Five of six animals getting the gene therapy showed decreased amounts of hepatitis C virus in the infected tissue. Two appeared to clear the virus completely, Richardson and his colleagues report in the May Nature Biotechnology. Mice that didn't get the gene ended up with severe damage in the transplanted liver tissue.

The therapeutic gene encodes a protein called BH3-interacting domain death agonist precursor (BID). This protein can trigger cell suicide, but only when cleaved by a type of enzyme not normally present in people or mice. The researchers modified the BID gene so that its protein is recognizable to an enzyme made specifically in cells infected with hepatitis C virus. In that way, only these cells cleave the BID protein and unleash a suicide signal.

The therapy works by killing infected cells before they can send out legions of hepatitis C viral particles to infect other cells, says Richardson. The signal doesn't appear to affect nearby healthy liver cells, he says.

The therapy may expose "an Achilles' heel of the virus," Richardson says. The researchers are now looking at ways other than an adenovirus to deliver the modified BID gene.--N.S.
COPYRIGHT 2003 Science Service, Inc.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2003, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

Article Details
Printer friendly Cite/link Email Feedback
Publication:Science News
Article Type:Brief Article
Date:May 31, 2003
Words:269
Previous Article:Taking a shine to number 100. (Physics).
Next Article:Humanity's pedestal lowered again? (Anthropology).
Topics:


Related Articles
Gene therapy seeks to mend cystic fibrosis.
HIV provides tools for gene therapy.
Gene therapy corrects mouse lupus.
Regrowing livers with gene therapy.
Gene therapy strategy repairs RNA, not DNA.
Cystic fibrosis controversy: a new theory hints that gene therapy in the womb can cure disease.
Gene therapy for sickle-cell disease? (Science News of the week).
Future jocks: in the next decade, cutting-edge gene research may cure hundreds of diseases. It may also help cheating athletes build superhuman...
RNAi: what's all the noise about gene silencing?
MIGENIX INITIATES ENROLLMENT IN PHASE IIB HEPATITIS TRIAL.

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters